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Rapid rise in the population of older adults in India will lead to the need for increased health care services related to diagnosis,
management, and long-term care for those with dementia and cognitive impairment. A direct approach for service provision
through memory clinics can be an eﬀective, successful, and sustaining means of delivering specialized health care services. We have
established a memory clinic in Mumbai, India by employing the diverse clinical skills available in Indian academic institutions,
diagnostic and research expertise of clinicians and psychologists, and the support of the U.S. National Institutes of Health. Our
project involved recruitment of patients, clinical and neuropsychological assessment, and standardized diagnostic procedures,
demonstrating the feasibility of using research methods to develop a memory clinic. In this paper, we describe the development of
a community-based memory clinic in urban India, including linguistic and cultural factors and present detailed results, including
diagnostic characterization, on 194 subjects with various stages of cognitive deficits. Our findings support the feasibility of
developing a memory clinic in a public hospital and successful use of research diagnostic criteria to categorize cognitive deficits
observed in this population, which may be used to inform the development of other such clinics.
1. Introduction
The mental health of aging persons in India is receiving
growing attention as the country is projected to be the
home of one of the world’s largest populations of elders
[1]. By 2025, the number of persons in India over 60 is
projected to reach over 150million [2]. In light of this rapidly
increasing population, dementia and cognitive impairment
are expected to increase as well. A comprehensive review of
mental health conditions in India across the lifespan summa-
rizes the growing problem of dementia [3]. Prevalence rates
of dementia in India over the past two decades ranged from
approximately 1.4% among those 65 years and older [4] to
3.5% among those 60 years and older [5] in rural settings;
in urban settings, prevalence rates were reported as 2.44%
among those 65 years and older [6]. Recently, however, crude
prevalence rates of dementia in India have been reported as
high as 10.6% in persons 65 and older living in rural areas
and 7.5% for those in urban areas [7].
Early detection of cognitive impairment and dementia is
critical to its management and will require developing the
capacity to eﬃciently evaluate and manage occurrence of
disease [8]. The establishment of specialized memory clinics
can provide the capacity to identify and treat dementia in
the population and can also act as a resource from which
information about disease and its management can be shared
with other practitioners and throughout the community.
Evaluations must be able to provide diﬀerential diagnoses
of specific subtypes of dementia and impairment and be
sensitive enough to capture staging of disease severity in
2 International Journal of Alzheimer’s Disease
order to direct appropriate interventions. Among developing
countries, as elsewhere, Alzheimer’s disease and vascular
dementia are the two most common types of dementia
observed [9]. The assessment of mild cognitive impairment
(MCI) may be more challenging in these populations due
to the lack of normative data across the breadth of socio-
economic strata that exists in a country as large as India.
Several research eﬀorts have reported assessing dementia
subtypes in India with commonly used measures. The
10/66 Dementia Research Group has successfully employed
dementia evaluations including neuropsychological tests in
cross cultural contexts in order to inform diagnoses of
Alzheimer’s type dementia based on DSM-IV criteria [10].
In addition, standardizedmeasures have been used to charac-
terize Alzheimer’s disease, vascular dementia, and dementia
with Lewy bodies [11, 12]. Neuropsychological evaluations
in this population have been used to diagnose mild cognitive
impairment [13] in some settings. These are encouraging
eﬀorts for the utility of commonly used dementia assessment
methods in developing countries such as India and support
the development of standardized dementia assessments
in memory clinics to evaluate and characterize cognitive
impairment.
Nonetheless, there are few reports of memory clinics
in India, particularly in public hospitals in medical school
settings where the patient population is diverse, and models
of clinical services need to accommodate the challenges of
multiple linguistic and cultural factors as well as educational
and economic extremes. In this paper, we report the results
of integrating commonly used research methods in dementia
evaluation with a diverse sample of older adults seen at a
public hospital. We also provide our experiences in dealing
with the challenges faced in assessing cognitive disorders in
this population.
Our research team established a memory clinic under the
Cognitive Disorders in the Elderly Joint Indo-US Dementia
Research Project in Mumbai, funded by an NIH/NIA/FIC
grant. This clinic was designed to facilitate clinical and neu-
ropsychological dementia evaluations and oﬀer participants
treatment options, as well as house dementia studies and
clinical trials. Clinical researchers from Mount Sinai School
of Medicine’s Alzheimer Disease Research Center (MSSM
ADRC) collaborated with clinicians in the Topiwala National
Medical College/Nair Charitable Hospital, a state-run public
hospital in Mumbai, India, in order to plan, coordinate,
and execute the establishment of the clinic in the hospital.
The purpose of this preliminary paper is to describe the
development of a memory clinic in Nair Charitable Hospital,
including the outreach process, the evaluation methods
including linguistic and cultural considerations, training the
clinical team, and developing consensus diagnostic proce-
dures, and describe the clinical population seen at the clinic.
2. Methods
2.1. Outreach Process. The clinic was established as a center
for individuals with memory and cognitive problems, which
oﬀered evaluation, treatment, and management including
education for families and caregivers. In order to raise
awareness about the utility of the services oﬀered at the
memory clinic, outreach eﬀorts focused on education about
dementia and cognitive disorders and included description
of the possible personal and social impact of these disorders.
The initial outreach for the clinic was made through the
departments of Psychiatry and Neurology at Nair Hospital
which are the home departments of the local Principal
Investigators of the research project. The broader medical
community was then engaged and informed of the clinic
through special lectures, seminars, and workshops sponsored
by Nair and open to the medical and aging care communities
throughout Mumbai.
2.2. Evaluations. The data reported here was collected from
patients seen in the memory clinic who underwent the
informed consent process for research as approved by the
Nair Charitable Hospital and Topiwala National Medical
College Ethics Committee. Informed consent procedures
for those who may not have been able to give consent
followed the ethical guidelines of the Nair Hospital Ethics
Committee, including obtaining a signature from a proxy.
While the clinic would provide the clinical evaluation
without consent, the consent allowed for summarizing and
reporting data from the clinical evaluation. Virtually all who
were asked to participate agreed to consent. Participants
were then administered a standardized clinical evaluation
and battery of neuropsychological tests. These instruments
were modeled after the National Alzheimer’s Coordinating
Center (NACC) standardized Uniform Data Set (UDS)
evaluation [14] (which is available at the following URL
http://www.alz.washington.edu/WEB/forms-uds.html) and
the MSSM ADRC’s clinical core assessment (available upon
request from the author, M. Sano).
The evaluation included a semistructured interview with
both the patient and an informant in order to provide
an accurate and comprehensive account of symptoms. In
addition to basic demographic information, a semistruc-
tured assessment of the presenting cognitive complaints, a
history of symptoms, a quantified functional assessment,
and measure of instrumental and basic activities of daily
living are collected. Psychiatric, medical, and family history
of dementia and cognitive loss were recorded. Laboratory
tests were ordered to rule out medical illnesses such as
B12 deficiency, thyroid illness, and acute infection when
needed. Medical comorbidities were recorded including
diabetes, hypertension, thyroid dysfunction, and coronary
and pulmonary disease. Global mental status and disease
severity were assessed using the Mini-Mental State Exami-
nation (MMSE) [15] or Hindi version of the MMSE [16]
and clinical dementia rating scale (CDR) [17]. Mood and
psychiatric disorders were assessed by patient and informant
(usually family)—reported history and with psychiatric and
behavioral symptom scales (Neuropsychiatric Inventory [18]
and Geriatric Depression Scale [19]). An adapted blessed
functional activity scale [20] assessed activities of daily living.
Neurological examination included the clinician assessment
of cognition, motor, and sensory function and a standardized
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assessment of extrapyramidal symptoms (EPS), based on
the UPDRS [21]. All participants were advised to undergo
clinical imaging (CT or MRI) however, since the procedure
was not included in this study, it is not available for all
cases. When available, scans were reviewed by the clinic’s
neurologist, and imaging results were recorded and discussed
during diagnostic consensus conferences.
2.3. Training the Clinical Team. The clinical team included
local neurologists, psychologists, and a social worker. A
study neurologist conducted the semistructured clinical
interviews and physical examinations. Study neurologists
were trained in administering the semistructured interview
through tutorial and observation of experienced ADRC
dementia clinicians. Master’s level psychologists (the min-
imum educational level required to practice psychology
in India) administered a neuropsychological assessment
(results not reported here). Standardized training procedures
for conducting the neuropsychological assessment included
viewing a standardized training DVD, observing neuropsy-
chological assessments performed by the senior psychologist
at the memory clinic, and administering neuropsychological
assessments under the supervision of a neuropsycholo-
gist. Deidentified copies of the neuropsychological scoring
protocols were sent to the MSSM ADRC psychometri-
cian who reviewed them for administration and scoring
errors and provided feedback. All staﬀ received training
and certification where available to conduct standardized
measures such as mental status (MMSE [15] or HMSE
[16]) and disease severity (CDR) [17]. We used standardized
training techniques which have been demonstrated to yield
reliable results [22]. A social worker facilitated clinical
visits and clinical followup, including visiting the home as
needed.
2.4. Diagnosis. Research diagnostic categories and methods
of assignment were modeled after the NACC Uniform Data
Set [14] and the MSSM ADRC. Diagnostic worksheets,
designed to be completed by a clinician, were created
to ensure classification was made according to published
criteria. All cases received a consensus diagnosis either
at an internal (Nair Hospital clinicians and staﬀ only)
or joint (Nair Hospital and MSSM clinicians and staﬀ)
consensus conference. Joint conferences were held during
site visits and over Skype conference calls, and all consensus
conferences were attended by at least one clinician and
one psychologist. Specific diagnostic categories were based
on standard research criteria: dementia of the Alzheimer’s
type, as outlined in the DSM-IV [23]; probable and pos-
sible Alzheimer’s disease (AD) [24]; probable and possible
Ischemic Vascular Dementia (VaD) [25]; mixed dementia,
defined as the presence of ischemic vascular dementia and
another systemic or brain disorder causing dementia [25];
dementia with Lewy bodies (DLBs) [26–28]; frontotemporal
dementia (FTD) [29]; mild cognitive impairment (MCI)
both amnestic and nonamnestic types [30]; other disorders,
such as psychiatric disorders, were diagnosed when standard
criteria was available.
2.5. Linguistic and Cultural Factors. Careful consideration of
linguistic and cultural factors was required prior to applying
the clinical research and assessment methodology described
above in this population. One of the first challenges was
identifying age or date of birth. Since some participants,
particularly those of low literacy, were not able to specifically
identify their age or date of birth, methods of approximation
were used. Such methodology included first asking the par-
ticipant or informant to spontaneously recall major histori-
cal events and temporally relate them to personal milestones
during childhood and adulthood. A prepared list of historical
events was then reviewed with the participant or informant
who was asked again to relate them to personal mile-
stones. Similar methodology has been previously described
[31].
Interview and assessment were completed in one of
four languages, English, Hindi, Marathi, and Gujarati
(among the most common languages spoken in Mumbai)
depending on the language the patient was proficient
in. All examiners were proficient in all four languages.
However, some cases required use of an interpreter (other
clinical staﬀ in the hospital). Separate interviews were
oﬀered with individual informants or family members in
order eliminate possible discomfort from discussing the
patient’s cognitive or functional diﬃculties in the pres-
ence of the patient. Additionally, staﬀ members of both
genders were available to discuss what may be viewed as
socially inappropriate behaviors with informants and family
members.
The high rate of illiteracy and low education in this
population required consideration and adaptation of evalu-
ation methods. The HMSE was used for those who were of
low literacy as items were adapted for illiterate rural Indian
populations [16]. Several assessment items required further
explanation (e.g., providing an example of what sentence
is) or concrete, real-world framing (e.g., subtracting rupees
for serial subtractions). Additionally, demonstrations were
oﬀered for alternating movement instructions during the
neurological exam.
2.6. Data Analysis. This paper summarizes demographic
and clinical features using descriptive statistics (mean, SD,
range, and frequency) for the cohort recruited between the
years 2006 and 2010. Diagnostic categories were enumerated
and demographics and medical history are provided for
major diagnostic groups. The HMSE has a maximum score
of 31, whereas the maximum MMSE is 30. In order to
combine scores across participants into one variable, the
HMSE was converted to a percent correct which was then
calculated out of 30 and was combined with MMSE scores
into one adjusted MMSE variable (this method has not been
validated). Demographic and medical comorbidity variables
were examined with one-way ANOVA (age and years of
education) or chi-square or Fisher’s exact test (gender,
medical comorbidities) to compare diﬀerences among the
three most common major diagnostic groups, AD, VaD, and
MCI. For the purposes of these analyses, MCI amnestic and
nonamnestic groups were combined into one MCI group
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[32]. All analyses were performed at the P = .05 level and
computed using SPSS 17.0 or 19.0 software.
3. Results
During the recruitment period, 212 participants were eval-
uated for cognitive complaint by Nair Hospital’s memory
clinic. The majority of these cases were referred by clinicians
from the Nair Neurology or Psychiatry Departments. Among
those who came to the clinic with a cognitive complaint, 18
did not receive a diagnosis: four were evaluated too soon after
acquiring an ischemic stroke to make an accurate diagnosis;
the clinical evaluation was not able to be completed for 13
cases; and in one case, the data was deemed insuﬃcient to
make a diagnosis. Therefore, this paper is based on data from
194 clinical cases. CT or MRI imaging results were available
on 135 of these 194 cases and available to the members of the
consensus conference when these cases were reviewed. Of the
194 cases, date of birth was approximated in 103 cases.
3.1. Demographics and Medical Conditions. Demographic
features and medical conditions of the sample are summa-
rized in Table 1. Notably, there is a high percentage of males
(64.4%) in this group. The medical conditions assessed are
also outlined in Table 1 (data on history of hypertension
and diabetes was not available on 3 of the clinical cases,
and data on the rest of the conditions was not available
on 4 clinical cases; percents are of cases for which data
was available). Hypertension was the most common medical
condition in the sample, observed in 45.9% of cases. Diabetes
and stroke were also present in approximately 20% of cases. A
high number (35.3%) of the clinical samples with completed
neurological exams (n = 187) were observed to have at
least one extrapyramidal symptom (e.g., resting tremor or
rigidity). Primary language was available for 192 cases, of
these Marathi was the most common (52.1%), followed by
Hindi (17.7%), Gujarati (10.4%), and others (19.8%).
3.2. Presenting Complaint. Among those cases seen in the
clinic, memory change was the most common presenting
complaint and was present in 66.5% of cases. The next
two most common presenting complaints were personality
change (13.5%) and change in behavior (12.4%). Few
participants complained of change in performance (8.3%),
language, (6.7%), disorientation (5.2%), depressed mood
(2.1%), or psychosis (5.2%). In twenty five clinical cases,
more than one presenting complaint was recorded.
3.3. Diagnostic Assignment. Of the 194 cases that were
referred to the clinic for a cognitive complaint and received a
diagnosis, 65.5% had a diagnosis of dementia (see Table 2).
Among those with dementia, 45.7% had AD (probable
or possible), 22% had VaD (probable or possible), 15%
had mixed dementia (coincident with VaD, progressive
dementias in this group included AD, DLB, and Parkinson’s
disease-related dementia), and 11% had FTD. The remaining
approximately 6% of dementia cases had other diagnoses
including dementia due to alcohol abuse or neurotrauma,
Table 1: Description of demographic features of the clinical group.
Clinical sample percent
(n = 194)
Age x = 65.10 (±9.90)
Education x = 7.79 (±5.44)
% Illiteracy 19.6%
%Male 64.4%
Hypertension 45.9%
Diabetes mellitus 20.1%
Myocardial infarction 5.7%
Congestive heart failure 6.7%
Chronic obstructive pulmonary
disease
2.1%
Thyroid disease 3.6%
History of stroke 19.6%
History of head injury with loss
of consciousness (>30min.)
10.8%
Parkinson’s disease 2.6%
Table 2: Summary of diagnoses in the clinical group.
Diagnosis
Dementia Count
Percent
(of dementia
diagnoses)
Alzheimer’s disease (probable or
possible)
58 45.7%
Ischemic vascular dementia (probable
or possible)
28 22.0%
Mixed dementia 19 15.0%
Frontotemporal dementia 14 11.0%
Other (alcohol abuse, neurotrauma) 3 2.4%
Dementia with Lewy bodies 2 1.6%
Vitamin B-12 deficiency 2 1.6%
Parkinson’s disease-related dementia 1 0.8%
Other Count
Percent
(of nondementia
diagnoses)
MCI 43 64.2%
Psychiatric disorder 19 28.4%
No dementia 5 7.5%
dementia with Lewy bodies, vitamin B-12 deficiency, or
Parkinson’s disease-related dementia.
Of the nondementia clinical cases, approximately 64.2%
were diagnosed as MCI (amnestic n = 33, and nonamnestic
n = 10), 28.3% had a primary psychiatric disorder (e.g.,
depression, schizophrenia, psychosis, etc.), and 7.5% were
not impaired.
3.4. Dementia Diagnoses. The three most common demen-
tia diagnoses were Alzheimer’s disease, vascular dementia,
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Table 3: Comparison of demographic and clinical measures among those with Alzheimers disease (AD), mild cognitive impairment (MCI),
and vascular Dementia (VaD).
Measure AD (n = 58) x(SD) MCI (n = 43) x(SD) VaD (n = 28) x(SD) Statistic
Age (years) 67.64 (±9.56)∗ 67.37 (±8.85)† 60.21 (±10.98)∗,† F(2, 126) = 6.29 (P < .01)
Education (years) 5.59 (±4.86)∗ 11.40 (±4.29)∗,† 7.14 (±5.04)† F(2, 126) = 19.11 (P < .01)
Gender (% male) 50.0%∗,† 74.4%∗ 92.8%†
P < .01 (Fisher’s exact, AD v.
VaD;); P = .01 (Fisher’s
exact, AD v. MCI;)
Adjusted MMSE (out of
30)
17.12 (±7.36)∗ (n = 55) 27.49 (±2.23)∗,† 16.30 (±8.55)† (n = 27) F(2, 122) = 38.84 (P < .01)
Blessed functional
activities scale (out of
17)
5.87 (±3.61)∗ (n = 57) 1.40 (±1.44)∗,† (n = 41) 7.12 (±4.68)† (n = 28) F(2, 123) = 30.12 (P < .01)
NPI total (out of 144)
42.14 (±27.87)∗
(n = 48)
17.03 (±20.08)∗,†
(n = 34)
43.37 (±27.31)†
(n = 19) F(2, 98) = 11.34 (P < .01)
GDS (out of 15) 6.72 (±4.10) (n = 39) 5.68 (±4.17) (n = 41) 6.50 (±3.26) (n = 18) F(2, 95) =.72 (P = .49)
CDR global (out of 5) 1.56 (±0.90)∗ (n = 46) 0.56 (±.36)∗,† (n = 35) 1.55 (±0.93)† (n = 21) F(2, 99) = 19.68 (P < .01)
∗,†Significant between diagnostic groups at the P = .05 level.
and mixed dementia. Significant diﬀerences (F(2, 102) =
5.16, P < .01) in age were found between the VaD (x =
60.21 ± 10.97) and AD (x = 67.64 ± 9.56) groups, but not
between the mixed dementia group (x = 65.05 ± 10.01)
and either other group. In addition, there was a significantly
higher frequency of females in the AD group (50%) and
mixed dementia groups (36.8%) than the VaD group (7.1%;
P < .001; and P = .02, resp.) however, no diﬀerences were
observed between the AD and mixed dementia groups (P =
.42). Hypertension was reported more frequently in the VaD
group (74.1%; data unavailable for one case) than in the AD
group (41.4%; P < .01) however, no diﬀerences were found
between the mixed dementia group (68.4%) and AD or VaD
groups. The groups did not diﬀer on any other demographic
(i.e., years of education, percent illiterate) variables.
3.5. MCI, AD, and VaD. AD and MCI participants were
found to be of similar age however, the VaD group was
significantly younger than both the AD andMCI groups (see
Table 3). Performance was compared on global measures of
cognition, function, and psychiatric symptoms between the
AD, MCI, and VaD groups (complete data for each measure
was unavailable for some cases in each of the diagnostic
groups). While there were no significant diﬀerences observed
between the AD and VaD groups on these measures, overall
significant diﬀerences were observed between both dementia
groups, AD and VaD, and the MCI group on all measures,
indicating worse cognition, worse functioning, and more
psychiatric symptoms in the dementia groups. There were
no diﬀerences observed on the geriatric depression scale
between any groups.
4. Discussion
This work described the challenges of establishing a memory
clinic in an urban Indian community and provides evidence
of the feasibility of evaluating a diverse patient population.
Key elements of the clinic that contributed to its success
included organized outreach eﬀorts, standardized evalua-
tions, training for the clinical team, and consensus-based
diagnostic processes.
While outreach eﬀorts were comprehensive, the majority
of referrals were from knowledgeable neurologists or psychi-
atrists seeking a comprehensive dementia evaluation for an
existing cognitive complaint. It was also likely that in most
cases the cognitive complaint was brought to the clinician
only after there was interference with activities of daily living.
Additionally, patients and family members who came to the
memory clinic displayed little knowledge or understanding
of dementia or cognitive impairment as amedical entity. This
highlights several important issues in this population: first,
despite receiving referrals predominantly from specialized
clinicians with expertise in dementia, there was considerable
uptake of thememory clinic’s services indicating the substan-
tial need for suchmemory clinics in this community. Second,
there remains a great need for education about dementia
and cognitive symptoms among general medical settings,
communities, and the public at large, beginning with raising
awareness about dementia as a distinct medical entity.
Cultural considerations were key to engaging the com-
munity. Since this is a culture that holds high respect for
elders, discussing what may be viewed as shortcomings (i.e.,
cognitive symptoms) can be viewed as a sign of disrespect.
Thus, separate, private interviews with individual informants
and family members were an important provision in order
to collect unhindered information about true deficits. Addi-
tionally, same-gendered interviewers also facilitated more
forthcoming discussion of behavioral symptoms that may be
viewed as socially inappropriate (e.g., hypersexuality, abusive
behaviors). In addition, some of the items of the basic and
instrumental activities of daily living were not culturally
relevant measures of functioning. For example, the item that
measures the participant’s ability to eat rates eating with
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one’s hands as impaired, but among this population eating
with one’s hands is quite common and culturally normal.
In such cases, the physician assessing the participant used
other items to determine a change from a previous level of
functioning. The spoken version of many Indian languages
lacks a term for dementia, and “memory impairment” is
frequently used to describe a wide range of deficits; thus,
exhaustive interviews with informants were often required
to obtain a clear understanding of the presentation. The
very low literacy of our sample also presented a challenge.
While illiteracy in India is high [33], our sample had
higher rate of illiteracy than the city of Mumbai [34],
which may be a result of recruitment through a state-run
hospital.
The distribution of our dementia diagnoses is similar to
other reports from India [6, 11, 35] and reports of memory
clinics from other developing countries [36, 37], with the
most common diagnosis of Alzheimer’s disease, followed by
vascular dementia. Alzheimer’s disease is recognized as the
most common type of dementia in both developed [38] as
well as in developing countries [9]. This complements the
known neuropathology which is similar in urban Indian
samples and urban samples from the US [39].
As a whole, there were more males than females in this
sample. However, the gender distribution is similar to that
of western cohorts when diagnostic category is taken into
account [40]. In particular, the high proportion of males
in the MCI group is comparable to that seen in western
samples [41], and a similar pattern in the VaD group has
been observed in other reports from memory clinics in India
[12]. It is unclear if this represents a diﬀerence in medical use
pattern or diﬀerential awareness or sensitivity to cognitive
complaints by gender.
Among the comorbidities assessed in this population,
hypertension surfaced as the most common medical comor-
bidity in both the clinical and comparison groups. Detected
hypertension is generally treated in this cohort; however,
this data was not available for this publication since initial
evaluations often depended on report of medication use
without confirmation from other service providers or from
more knowledgeable family members. The prevalence of
hypertension in the Indian population is receiving increased
attention, as it may become a serious health concern
among the nation’s population of older adults [42, 43].
Hypertension has been found to be a significantly higher
risk factor for vascular dementia than AD in other urban
Indian samples [13]; in our sample, hypertension was more
frequently found in the VaD and mixed dementia groups
than in the AD group. In light of the high frequency of
hypertension observed here and in other studies, and of the
known contribution to vascular disease, future studies might
determine its contribution to the rate of cognitive decline in
neurodegenerative illness.
As expected, the cognitive, functional, and psychiatric
measures successfully characterized the dementia, AD and
VaD, and MCI groups. The AD and VaD groups were
observed to be more cognitively and functionally impaired
than the MCI group, and the AD and VaD groups also
had more neuropsychiatric symptoms than the MCI group.
All groups endorsed a comparable, subthreshold number of
items on a depression scale.
We note that the age of this cohort is younger than
many identified in western countries. Yet it is not dissimilar
from ages reported from other clinical cohorts in India
with dementia [11, 12]. This is probably not surprising in
a setting where illiteracy is high and education is low [35].
Educational achievement is rapidly changing in India as is
life expectancy, and with this, we may expect to see a shift
in the demographic characteristics of the clinical population.
Additionally, in our sample, the MCI group was found to
be more highly educated than the AD and VaD groups.
This discrepancy may reflect a higher self-awareness in the
MCI group, prompting them to be clinically examined at
an early indication of some impairment. These findings
highlight the need to include sensitive measures to capture
the sometimes subtle cognitive and functional changes in
MCI across educational levels. In addition, clinical outreach
and educational eﬀorts should be attentive to the wide range
of education in this older population and how that may
impact initial cognitive complaint.
Our sample is one of convenience and may not represent
the population as a whole, but it may be representative of
those who seek treatment at a public hospital. However,
an advantage of assessing a clinical population is that the
cases are referred with clear complaint and often functional
deficits. When clinical history can document decline in
cognition and function, the need to depend solely on nor-
mative neuropsychological testing is mitigated. In the clinical
setting, the demand for normative data to characterize
subtle deficits may be greatest within the average educational
spectrum and across many cultural factors. Future studies
that hope to capture the earliest cognitive changes in healthy
populations should be mindful of the high rate of illiteracy
in India, and prepare a diverse battery of neuropsychological
measures accordingly taking into account the education,
language, and concepts within the culture to truly make the
evaluation bias free.
In several cases, participants had never encountered a
testing situation before, a limitation commonly observed in
developing countries [44], and while great care was taken
to provide adequate explanation and comfort in the testing
environment, performance may have been aﬀected by the
novelty of the situation. Future research studies and memory
clinics should explain the nature of the tests and address any
anxiety related to assessment prior to the testing. Among
several participants, exact birthdates were unknown but
estimated by the participant and his or her family, and in
some cases, age was also estimated. Such a limitation has
been found in other studies conducted in India, as well [45].
In summary, this paper demonstrates the feasibility of
developing a memory clinic as described here and the
value of using global measures of cognition and measures
of functioning and psychiatric symptoms to characterize
cognitive impairment in an urbanmemory clinic in India. As
other memory clinics in India have also successfully used the
CDR, NPI, and MMSE to inform dementia diagnosis [12],
taken together the application of thesemeasuresmay support
their use as best clinical practices in this population. Further,
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our results also support the utility of applying research
diagnostic criteria to diagnose diﬀerent dementia types and
MCI in this population.
Developing memory clinics and integrating research
evaluation methods can lead to early detection of impair-
ment and dementia and also facilitates the development of
clinical trials and other research protocols in this population.
Based on our experience, what is critical to the development
of a memory clinic are devoted oﬃces and treatment rooms,
standardized assessment methods, a clinical team with
clearly defined roles, standardized diagnostic procedures,
and regular consensus conferences. It is likely that most
of the resources needed to develop a memory clinic are
already present in hospital settings. Hospitals may be able
to allocate oﬃces and treatment rooms for this purpose,
and existing staﬀ may be able to fill the roles of the clinical
team through a training program that promotes capacity
building. As the population of older adults in India grows,
it will be necessary to prepare to meet the needs of this
population, through the continued development of clinical
research and memory clinics such as the one reported
here.
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